RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+32.75%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$1.01B
AUM Growth
+$1.01B
(+45%)
Cap. Flow
+$162M
Cap. Flow
% of AUM
16%
Top 10 Holdings %
Top 10 Hldgs %
64.85%
Holding
53
New
6
Increased
8
Reduced
14
Closed
16
Top Buys
| 1 |
Wave Life Sciences
WVE
|
$113M |
| 2 |
Aclaris Therapeutics
ACRS
|
$69.1M |
| 3 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
$20.4M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$19.6M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$16.6M |
Top Sells
| 1 |
Collegium Pharmaceutical
COLL
|
$19.1M |
| 2 |
BLUE
bluebird bio
BLUE
|
$14.3M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$12.6M |
| 4 |
Ardelyx
ARDX
|
$8.93M |
| 5 |
TherapeuticsMD
TXMD
|
$8.9M |
Sector Composition
| 1 | Healthcare | 84.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACHN
1
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $121M | 11.98% | 11,222,893 -510,922 | -4% | -$5.51M |
|
|
2
Wave Life Sciences
WVE
$1.53B
| $113M | 11.19% | +7,088,651 | New | +$113M |
|
|
DYAX
3
DELISTED
DYAX CORPORATION
DYAX
| $102M | 10.12% | 2,717,618 +166,425 | +7% | +$6.26M |
|
|
SIOX
4
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $90.2M | 8.92% | 5,000,000 | – | – |
|
|
5
Aclaris Therapeutics
ACRS
$209M
| $69.1M | 6.84% | +2,564,553 | New | +$69.1M |
|
6
TG Therapeutics
TGTX
$4.65B
| $33.6M | 3.32% | 2,813,779 -310,701 | -10% | -$3.71M |
|
|
ZGNX
7
DELISTED
Zogenix, Inc.
ZGNX
| $33.2M | 3.29% | 2,253,237 +573,737 | +34% | +$8.46M |
|
|
8
BioCryst Pharmaceuticals
BCRX
$1.74B
| $31.9M | 3.16% | 3,094,064 +1,897,461 | +159% | +$19.6M |
|
9
Ascendis Pharma
ASND
$11.8B
| $30.6M | 3.03% | 1,671,447 +210,179 | +14% | +$3.85M |
|
|
RGLS
10
DELISTED
Regulus Therapeutics
RGLS
| $30.4M | 3.01% | 3,482,924 -556,899 | -14% | -$4.86M |
|
11
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $29.2M | 2.89% | 1,272,048 -32,972 | -3% | -$757K |
|
|
DRNA
12
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $28.8M | 2.85% | 2,428,571 | – | – |
|
|
13
Collegium Pharmaceutical
COLL
$1.22B
| $23.6M | 2.33% | 857,683 -695,492 | -45% | -$19.1M |
|
|
BPMC
14
DELISTED
Blueprint Medicines
BPMC
| $23.1M | 2.29% | 878,348 | – | – |
|
15
Protara Therapeutics
TARA
$120M
| $22.9M | 2.27% | 1,476,931 -29,941 | -2% | -$464K |
|
|
SBBP
16
DELISTED
Strongbridge Biopharma plc.
SBBP
| $20.4M | 2.02% | +2,690,702 | New | +$20.4M |
|
17
Neurogene
NGNE
$264M
| $20.2M | 2% | 1,619,977 +87,826 | +6% | +$1.1M |
|
18
Sangamo Therapeutics
SGMO
$157M
| $20.2M | 2% | 2,212,036 +766,606 | +53% | +$7M |
|
19
Cidara Therapeutics
CDTX
$1.66B
| $20.2M | 1.99% | 1,174,219 -6,351 | -0.5% | -$109K |
|
20
Arcturus Therapeutics
ARCT
$462M
| $19M | 1.88% | 3,032,911 +1,200,000 | +65% | +$7.54M |
|
|
ARNA
21
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $16.6M | 1.64% | +8,714,482 | New | +$16.6M |
|
|
GBT
22
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $14.8M | 1.46% | 457,142 | – | – |
|
|
AIMT
23
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $14.6M | 1.44% | 790,200 | – | – |
|
|
DMTX
24
DELISTED
Dimension Therapeutics, Inc
DMTX
| $12.3M | 1.21% | +1,087,930 | New | +$12.3M |
|
|
25
Ardelyx
ARDX
$1.53B
| $10.4M | 1.02% | 571,444 -492,569 | -46% | -$8.93M |
|